Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 5/20 | 0.50 |
| ▸ | DHODH | Q02127 | 4/20 | 0.45 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | TNF | P01375 | 1/20 | 0.40 |
| ▸ | ADK | P55263 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1821476 | 0.81 | DHODH (0.50) | ABCG2DHODHMEN1KMT2AALDH1A1 | |
| SCHEMBL4721393 | 0.78 | DHODH (0.58) | ABCG2DHODHMEN1KMT2AALDH1A1 | |
| SCHEMBL15401372 | 0.77 | FABP3 (0.46) | MEN1KMT2AALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL28468092 | 0.77 | ALDH1A1 (0.60) | ABCG2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL2817231 | 0.76 | ABCG2 (0.38) | ABCG2DHODHALDH1A1MAPK1 | |
| SCHEMBL17154885 | 0.75 | DHODH (0.47) | ABCG2DHODHMEN1KMT2AALDH1A1 | |
| SCHEMBL29648441 | 0.75 | FABP3 (0.47) | ABCG2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL15987640 | 0.75 | FABP3 (0.47) | ABCG2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL3807873 | 0.74 | DHODH (0.77) | DHODHMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL28033303 | 0.74 | PTGS2 (0.59) | MEN1KMT2AALDH1A1GAASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101747262-B | Electron transport-injection compound and organic electroluminescent device using the same | LG DISPLAY CO LTD | 2012-11-07 | — | — | CN | disclosed |
| CN-102617456-A | Electron transporting-injection compound and organic electroluminescent device using the same | LG DISPLAY CO LTD | 2012-08-01 | — | — | CN | disclosed |
| US-20100164371-A1 | ELECTRON TRANSPORTING-INJECTION COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LG. DISPLAY CO. LTD. (KR) | 2010-07-01 | — | — | US | disclosed |
| CN-101747262-A | Electron transport-injection compound and organic electroluminescent device using the same | LG DISPLAY CO LTD | 2010-06-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100164371-A1 | ELECTRON TRANSPORTING-INJECTION COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | SLCO4C1, SLCO2A1, SLCO2B1 | ABCG2 364/4885DHODH 1912/4885EPAS1 2698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.